Perennial Future of Healthcare Fund
Start investing in a blend of innovative healthcare companies today.
Comparison Data
1Performance
| 1 month | 3 month | 1 year | 3 year | 5 year | Since Inception | Inception Date |
|---|---|---|---|---|---|---|
| -3.83% | 8.57% | -1.23% | 11.3% | - | 6.84% | 8 Apr 2021 |
Fees
| Management Fee | Performance Fee | Morningstar Total Cost Ratio |
|---|---|---|
| 1.3% | - | 1.55% |
The Future of Healthcare Fund makes targeted investments in pharmaceuticals, biotechnology, medical equipment, health IT, life sciences and health services companies that seek to significantly impact clinical outcomes worldwide, this potential ultimately drives the financial returns for the Fund’s investors.
The Fund has two allocations that are aligned with the Fund’s investment objective :
- Venture capital and private equity – predominantly growth investments in innovative businesses; and
- Listed equities – investments in domestic and international companies.
The Future of Healthcare Fund provides wholesale investors with the opportunity to invest with a highly experienced healthcare team investing to generate long term capital growth from investments that enhance health and wellbeing.
The Trust invests in a portfolio of Australian and internationals investments addressing key healthcare issues such as those associated with an ageing population, rise of chronic and communicable disease, disability, mental health and wellbeing.
We see the thematic of ageing demographics combined with rising health care needs and the development, adoption and diffusion of innovative healthcare products as long-term fundamental trends supporting the healthcare sector and the Trust.
The cornerstone of this approach is a strong emphasis on company research. The aim is to develop a detailed understanding of each company before committing investors’ funds.
The Trust makes targeted investments in pharmaceuticals, biotechnology, medical equipment, health IT, life sciences and health services companies that seek to significantly impact clinical outcomes. Central to the Trust’s philosophy is our view that it is the clinical benefit that ultimately drives the financial returns of healthcare companies and of the Trust’s investors.
The portfolio will typically hold in the range of 30 to 60 stocks.
Investment Strategy
The Future of Healthcare Fund intends to have two primary allocations that are aligned with the Fund’s investment objective (including investments relating to the health, retirement and aged care sectors):
- Venture capital and private equity – predominantly growth investments in innovative businesses; and
- Listed equities – investments in domestic and international companies.
Asset classes and asset allocation ranges
| Asset Class | Allocation |
| Venture capital and private equity | 0 – 40% |
| Listed equities | 35 – 100% |
| Cash | 0 – 25% |
Objective
Primary objective: To generate long-term capital growth from providing strategic capital investment to address key issues of an ageing population, rise of chronic disease, disability, mental health and wellbeing.
Investment Return Objective
The aim of the Trust is to generate pre-fee returns in excess of the MSCI World Healthcare Net Return Index Unhedged in AUD +3.0% p.a. over rolling five-year periods.
The Trust is authorised to utilise derivative instruments for risk management purposes, subject to the specific restriction that they cannot be used to gear portfolio exposure.
Perennial Partners is a house of specialist investment teams. We partner with outstanding investment people pursuing great investment outcomes in segments where active management can add meaningful value.
Uncovering great investment opportunities requires talent and focus. Perennial Partners has built a reputation for investment excellence by creating a family of highly qualified investment teams.
We provide our investment partners with strategic, operational and distribution expertise and access to an investor base made up of financial advisers, wealth managers, institutional, high net worth and family offices, while allowing them to focus on managing money.
Our ‘clients first’ culture underpins everything we do.
At Perennial Partners we believe in true alignment, our business and investment partners are wholly owned by executives and we co-invest in our strategies alongside our clients and on the same terms. This means that we have true ‘skin in the game’, creating a powerful alignment of interests with our clients.
Future of Healthcare Fund: 5 years
Industry: 25+ years
Future of Healthcare Fund: 5 years
Industry: 15+ years
Click here to view our Latest Commentary.
Click here to view our latest Insights
Statutory Statement
This offer of scheme interests is available to wholesale clients only. This product listing was vetted by and approved by the product issuer identified above before publishing. Investment Markets (Aust) Pty Ltd AFSL 527875 (IM) is not the issuer of the product.
General Disclaimer
IMPORTANT STATEMENT ABOUT YOUR USE OF THIS SITE
Information on this site is intended for Australian users only.
This site is operated by Investment Markets (Aust) Pty Ltd. (ACN 634 057 248) (IMA, we, us and our), the holder of Australian Financial Services Licence (AFSL) no. 527875. The content is provided solely for information purposes, is not a recommendation or an offer to buy or sell a security, and is not warranted to be correct, complete or accurate. To the extent permitted by law, neither IMA, its affiliates, nor the content providers (such as the issuers of securities who appear on the site) are responsible for any investment decisions, damages or losses resulting from, or related to, the content, data and analyses or their use. The investment products on this site and any statements made about them by their issuers are not vetted, verified or researched by IMA. The presence of an investment product on this site should not be interpreted as an implied endorsement of it by IMA. Certain content provided may constitute a summary or extract of another document such as a Product Disclosure Statement. To the extent any content is general advice, it has been prepared by IMA. Any general advice has been provided without reference to your investment objectives, financial situations or needs. For more information refer to our Financial Services Guide. To obtain advice tailored to your situation, contact a financial advisor. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (or other offer document) before making any decision to invest. Past performance does not necessarily indicate an investment product’s future performance. The content is current as at date of initial publication and may not be current as at your date of viewing. For a more complete understanding of all the terms and conditions of your use of this site click here.
1 For use in Australia: © 2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its affiliates or content providers; (2) may not be copied, adapted or distributed; (3) is not warranted to be accurate, complete or timely and 4) has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), subsidiary of Morningstar. Neither Morningstar nor its content providers are responsible for any damages arising from the use and distribution of this information. Past performance is no guarantee of future results.
Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at http://www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Morningstar's publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar's full research reports are the source of any Morningstar Ratings and are available from Morningstar or your advisor. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a financial advisor. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.